321 Shares in U.S. Physical Therapy, Inc. (NYSE:USPH) Bought by Innealta Capital LLC

Innealta Capital LLC bought a new position in U.S. Physical Therapy, Inc. (NYSE:USPH) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 321 shares of the company’s stock, valued at approximately $30,000.

Several other hedge funds also recently made changes to their positions in the company. Albert D Mason Inc. increased its stake in shares of U.S. Physical Therapy by 1.1% in the first quarter. Albert D Mason Inc. now owns 10,489 shares of the company’s stock worth $1,184,000 after buying an additional 111 shares during the period. Conestoga Capital Advisors LLC grew its position in shares of U.S. Physical Therapy by 1.0% in the 1st quarter. Conestoga Capital Advisors LLC now owns 15,075 shares of the company’s stock worth $1,702,000 after buying an additional 145 shares during the last quarter. Texas Permanent School Fund Corp increased its stake in shares of U.S. Physical Therapy by 1.3% during the first quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company’s stock valued at $1,480,000 after buying an additional 170 shares during the period. First Horizon Advisors Inc. raised its holdings in shares of U.S. Physical Therapy by 18.6% during the second quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock valued at $110,000 after acquiring an additional 186 shares in the last quarter. Finally, Louisiana State Employees Retirement System lifted its stake in U.S. Physical Therapy by 2.7% in the second quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock worth $702,000 after acquiring an additional 200 shares during the period.

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,724 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the transaction, the chief operating officer now owns 7,038 shares of the company’s stock, valued at approximately $580,635. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Price Performance

USPH opened at $85.60 on Friday. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.28. The company has a market cap of $1.29 billion, a price-to-earnings ratio of 69.59, a price-to-earnings-growth ratio of 4.07 and a beta of 1.38. The stock has a fifty day simple moving average of $91.08 and a two-hundred day simple moving average of $98.82. U.S. Physical Therapy, Inc. has a 12-month low of $78.08 and a 12-month high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The business had revenue of $167.19 million during the quarter, compared to the consensus estimate of $163.34 million. During the same quarter in the previous year, the business earned $0.76 earnings per share. The firm’s revenue was up 10.4% compared to the same quarter last year. Research analysts predict that U.S. Physical Therapy, Inc. will post 2.55 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 13th. Stockholders of record on Friday, August 23rd will be issued a dividend of $0.44 per share. The ex-dividend date is Friday, August 23rd. This represents a $1.76 annualized dividend and a dividend yield of 2.06%. U.S. Physical Therapy’s payout ratio is 143.09%.

Wall Street Analyst Weigh In

Several research analysts have commented on USPH shares. Barrington Research decreased their price objective on shares of U.S. Physical Therapy from $122.00 to $108.00 and set an “outperform” rating for the company in a report on Thursday, August 15th. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. One research analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $112.50.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.